Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
ZS PRIZE is a healthcare innovation award that aims to recognise, celebrate and advance innovation in healthcare that uses data, analytics and technology to create outcomes that are affordable, accessible and scalable.
This is a phase two randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two treatment period study to evaluate the safety and efficacy of Itolizumab for the induction of remission in biologics naive patients with moderate to severely active Ulcerative Colitis (UC), Biocon said in a statement.
In his new role, Shalabh Dang will be responsible for driving and implementing strategic partnerships with hospitals, corporates, and other channels to boost revenue growth and support the company's mission of creating a 911 model for Indian healthcare.
The Lancet revealed that Africa followed Asia (20%), Europe (10%) and Latin America (10%) and more than half of deaths were estimated in Asia (58%) followed by Africa (22%), and Latin America (9%).
British drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, despite the US court last week ruling that there is no sound scientific evidence to back the claims that the drug increases the risk of cancer.
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
The acquisition will be funded through long term debt and internal accruals. Razel ranks among the top 10 brands in India in the rosuvastatin molecule category, with the combined sales of Rs 66.1 crore as of year end October 2022 as per IQVIA data.